Market for analytical and life science instruments projected to grow by 4.6%

LOS ANGELES, Feb. 28, 2018 -- Strategic Directions International (SDi), a division of BioInformatics LLC, today announced the release of the 2018 Global Assessment Report: The Laboratory Analytical & Life Science Instrumentation Industry. The 800+ page report details the size, growth and depicts market analysis for over 50 instruments in 6 technology categories. In addition, projections are made on the industry’s prospects out to 2022 and include technology overviews, and detail market segment and regional developments. For this first time, users of the report will have an option to receive an electronic data stream updating the market projections on a quarterly basis.

“The overall analytical instrument industry is expected to grow by 4.6% reaching $71 billion by 2022,” said Mike Tice, Vice President of Consulting at SDi. “Tax policy changes in the US are helping to stimulate growth in North America and the stock market volatility in February 2018 is not expected to affect the outlook for economic growth in the long term. The continuing economic recovery of most European countries and the increased manufacturing output in Asia will also prove favorable to instrument sales.”

The SDi Global Assessment Report 2018: The Laboratory Analytical & Life Science Instrumentation Industry is the gold standard for measuring the size and growth of the analytical and life science instrumentation industry. A complimentary Executive Summary can be downloaded here. More information on the Global Datastream, which includes not only the Global Assessment report, but also quarterly updates, can be found here. Additionally, users will receive the report in a pdf as well as editable powerpoint format.

The report covers 82 individual instrumentation and related technologies. Each technology is segmented according to several primary classifications typically related to underlying techniques.  The 6 sections to be updated annually include chromatography, life science instrumentation, mass spectrometry, molecular spectroscopy, atomic spectroscopy, and lab equipment. The rest will be updated every 2 years, and the surface science, materials characterization, lab automation, and general analytical techniques categories will contain an updated and extensive technology overview.

For each instrument and category, the report quantifies the regional distribution of demand; the size of the market segmented according to initial systems, aftermarket, and service; unit shipments/installations; growth rates; and demand by industry and lab function.  Each section also explores the current state of the competitive playing field, including a list of the top vendors’ market shares, a vendor participation matrix, recent developments, and concludes with a short discussion that suggests where the market might be headed over the next five years from the related standpoints of technology, competition, and growth.

ABOUT IBO and BIOINFORMATICS LLC

Strategic Directions International (SDi), a leading international management-consulting firm in the highly specialized field of analytical instruments, was acquired by BioInformatics LLC in 2014. The two firms combined to form the premier research and advisory firm serving the life science and analytical instrument industry. By leveraging our online professional network of tens of thousands of scientists, we have supported more than 500 companies and provided insights that lead to better business decisions. Our expertise includes assessing the size and attractiveness of markets, optimizing product configurations and pricing, validating corporate acquisitions, measuring customers’ brand loyalty, and evaluating brand strength and positioning, validating corporate acquisitions, measuring customer loyalty, and evaluating brand strength and positioning.
www.gene2drug.com

Other statistics that could be used:

•The largest market, life science instrumentation, is expected to swell from about $15 billion in 2017 to $19.6 billion in 2022, at a rate of 5.5%. Its main driver is next generation sequencing. However, growth is expected to be offset by a gradual softening of demand from pharmaceuticals over the next few years.

•As the technology often on the leading edge of scientific research capabilities, mass spectrometry continues to have a bright future as the fastest-growing instrument segment, expected to grow by almost 7%. Surface science techniques are also poised to make great gains, buoyed by growing opportunities in life science applications

•China is projected to have the highest analytical instrument demand by 2022 with a 7.3% CAGR.

Brochure link:
( https://www.gene2drug.com/product/2018-sdi-global-report-life-science-analytical-instrumentation/)

Datastream link:
https://www.gene2drug.com/product/2018-sdi-global-assessment-datastream/

For more information contact:

Mike Tice
Vice President of Consulting
Strategic Directions International
A division of BioInformatics LLC
6242 Westchester Parkway, Suite 100
Los Angeles, CA 90045-4820
United States
Phone: 310.641.4982
[email protected]
www.gene2drug.com